Schizophrenia drug says goodbye to dopamine

Daniel R. Weinberger

doi:10.1038/nm0907-1018

Schizophrenia drug says goodbye to dopamine

Daniel R. Weinberger

Research output: Contribution to journal › Short survey › peer-review

45 Scopus citations

Abstract

A drug that activates glutamate receptors offers promise for a new class of anti-psychotic therapeutics and sheds light on the pathophysiology of this devastating disease (pages 1102-1107).

Original language	English (US)
Pages (from-to)	1018-1019
Number of pages	2
Journal	Nature medicine
Volume	13
Issue number	9
DOIs	https://doi.org/10.1038/nm0907-1018
State	Published - Sep 2007
Externally published	Yes

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1038/nm0907-1018

Cite this

@article{14e1e5cf15964f3f95d800a8af323b2f,

title = "Schizophrenia drug says goodbye to dopamine",

abstract = "A drug that activates glutamate receptors offers promise for a new class of anti-psychotic therapeutics and sheds light on the pathophysiology of this devastating disease (pages 1102-1107).",

author = "Weinberger, {Daniel R.}",

year = "2007",

month = sep,

doi = "10.1038/nm0907-1018",

language = "English (US)",

volume = "13",

pages = "1018--1019",

journal = "Nature medicine",

issn = "1078-8956",

publisher = "Nature Research",

number = "9",

}

TY - JOUR

T1 - Schizophrenia drug says goodbye to dopamine

AU - Weinberger, Daniel R.

PY - 2007/9

Y1 - 2007/9

N2 - A drug that activates glutamate receptors offers promise for a new class of anti-psychotic therapeutics and sheds light on the pathophysiology of this devastating disease (pages 1102-1107).

AB - A drug that activates glutamate receptors offers promise for a new class of anti-psychotic therapeutics and sheds light on the pathophysiology of this devastating disease (pages 1102-1107).

UR - http://www.scopus.com/inward/record.url?scp=34948873609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34948873609&partnerID=8YFLogxK

U2 - 10.1038/nm0907-1018

DO - 10.1038/nm0907-1018

M3 - Short survey

C2 - 17828217

AN - SCOPUS:34948873609

SN - 1078-8956

VL - 13

SP - 1018

EP - 1019

JO - Nature medicine

JF - Nature medicine

IS - 9

ER -

Schizophrenia drug says goodbye to dopamine

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this